Gd complexes of DO3A-(biphenyl-2,2′-bisamides) conjugates as MRI blood-pool contrast agents

Ki Hye Jung, Hee Kyung Kim, Ji Ae Park, Ki Soo Nam, Gang Ho Lee, Yongmin Chang, Tae Jeong Kim

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

We report the synthesis of DO3A derivatives of 2,2′-diaminobiphenyl (1a,b) and their Gd complexes of the type [Gd(1)(H2O)]·xH 2O (2a,b) for use as new MRI blood-pool contrast agents (BPCAs) that provide strong and prolonged vascular enhancement. Pharmacokinetic inertness of 2 compares well with that of structurally related Dotarem, a DOTA-based MRI CA currently in use. The R1 relaxivity in water reaches 7.3 mM -1 s-1, which is approximately twice as high as that of Dotarem (R1 = 3.9 mM-1 s-1). They show interaction with HSA to give association constants (Ka) in the order of two (∼102), revealing the existence of the blood-pool effect. The in vivo MR images of mice obtained with 2 are coherent, showing strong signal enhancement in both heart, abdominal aorta, and small vessels. Furthermore, the brain tumor is vividly enhanced for an extended period of time.

Original languageEnglish
Pages (from-to)1003-1007
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume3
Issue number12
DOIs
StatePublished - 13 Dec 2012

Keywords

  • DO3A
  • Gd chelates
  • MRI BPCA
  • biphenyl
  • brain tumor

Fingerprint

Dive into the research topics of 'Gd complexes of DO3A-(biphenyl-2,2′-bisamides) conjugates as MRI blood-pool contrast agents'. Together they form a unique fingerprint.

Cite this